{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -6.76238, "regularMarketPrice": 0.9417, "exchange": "ASE", "shortName": "iBio, Inc.", "longName": "iBio, Inc.", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1219152600000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.0683, "regularMarketTime": 1684180729, "regularMarketDayHigh": 1.01, "regularMarketDayRange": "0.9 - 1.01", "regularMarketDayLow": 0.9, "regularMarketVolume": 424506, "regularMarketPreviousClose": 1.01, "bid": 0.8999, "ask": 1.1, "bidSize": 9, "askSize": 14, "fullExchangeName": "NYSE American", "financialCurrency": "USD", "regularMarketOpen": 1.0, "averageDailyVolume3Month": 3061933, "averageDailyVolume10Day": 171190, "fiftyTwoWeekLowChange": 0.58169997, "fiftyTwoWeekLowChangePercent": 1.6158332, "fiftyTwoWeekRange": "0.36 - 16.5", "fiftyTwoWeekHighChange": -15.5583, "fiftyTwoWeekHighChangePercent": -0.9429273, "fiftyTwoWeekLow": 0.36, "fiftyTwoWeekHigh": 16.5, "dividendDate": 1528675200, "earningsTimestamp": 1684157220, "earningsTimestampStart": 1684157220, "earningsTimestampEnd": 1684157220, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -138.17, "epsForward": -1.09, "epsCurrentYear": -4.78, "priceEpsCurrentYear": -0.19700836, "sharesOutstanding": 12369200, "bookValue": 1.522, "fiftyDayAverage": 1.5016, "fiftyDayAverageChange": -0.55990005, "fiftyDayAverageChangePercent": -0.37286896, "twoHundredDayAverage": 2.70555, "twoHundredDayAverageChange": -1.76385, "twoHundredDayAverageChangePercent": -0.65193766, "marketCap": 12224678, "forwardPE": -0.8639449, "priceToBook": 0.61872536, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "displayName": "iBio", "symbol": "IBIO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "8800 HSC Parkway", "city": "Bryan", "state": "TX", "zip": "77807-1107", "country": "United States", "phone": "979 446 0027", "website": "https://www.ibioinc.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates through two segments, Biopharmaceuticals and Bioprocessing. Its lead anti-fibrotic candidate is IBIO-100 for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-202 , which is the Nucleocapsid (N) protein for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties; and offers a range of process development, manufacturing, and bio analytic services. iBio, Inc. has a license agreement with University of Pittsburgh; a non-exclusive agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with RubrYc. The company was incorporated in 2008 and is headquartered in Bryan, Texas.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 51, "title": "Interim CEO & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 578302, "fmt": "578.3k", "longFmt": "578,302"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert B. Kay", "age": 82, "title": "Interim Sec. & Interim Treasurer", "yearBorn": 1940, "fiscalYear": 2022, "totalPay": {"raw": 92692, "fmt": "92.69k", "longFmt": "92,692"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 42, "title": "Interim Chief Financial Officer", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mike  Jenkins", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Stephen  Kilmer", "title": "Investor Relations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nick  DeLong Ph.D.", "title": "VP of Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lisa  Middlebrook", "title": "Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}